Several treatable conditions can be mistaken for irritable bowel syndrome (IBS), a gut-brain disorder diagnosed from a symptom pattern. The ones that come up most are celiac disease, inflammatory bowel disease (IBD), bile acid diarrhea, microscopic colitis, small intestinal bacterial overgrowth (SIBO), lactose or fructose malabsorption, exocrine pancreatic insufficiency, thyroid disease, pelvic floor dysfunction and, in women, endometriosis. Medicines can do it too, and rarely, so can ovarian or bowel cancer. IBS is diagnosed from a symptom pattern, so anything that produces that pattern can wear the label for a while.
This is not a reason to distrust an IBS diagnosis. For most people who meet the criteria and have no alarm features, IBS is the right answer and a long exclusion work-up adds cost without adding much. But if you have lived with the label for years and something does not fit, or you are being assessed now and wondering what your doctor is ruling out, it helps to know the list. The pages that rank for this question mostly give names. Here you get a table that pairs each look-alike with the clue that tends to separate it and the test that checks it, each with a source.
Nothing in this article can tell you which condition you have, or that you do not have one. It is meant to help you ask better questions and show up with better information. If you want a plain-English explanation of how the diagnosis itself works first, our guide to IBS versus IBD and the Rome IV checker are good starting points.
The short answer: what is usually mistaken for IBS?
The conditions most often found in people who were told they have IBS are bile acid diarrhea, carbohydrate (lactose and fructose) malabsorption and SIBO, with celiac disease, microscopic colitis, pancreatic insufficiency and IBD less common but important because they are treatable and have different long-term consequences. That ordering comes from a 2022 systematic review of studies in secondary care (Poon 2022).
Here is what that review found when it pooled studies of consecutive people who met diagnostic criteria for IBS: For specific overlaps and the diagnostic route, see IBS vs bowel endometriosis, can IBS be diagnosed without a colonoscopy? and is IBS a real diagnosis?.
| Condition found | Pooled prevalence in people meeting IBS criteria |
|---|---|
| Bile acid diarrhea | 41% (7 studies, 597 people) |
| Lactose malabsorption (breath testing) | 54% (26 studies, 6,700 people) |
| Fructose malabsorption (breath testing) | 43% (13 studies, 3,415 people) |
| SIBO (lactulose breath test) | 49% (36 studies, 4,630 people) |
| SIBO (glucose breath test) | 19% (22 studies, 2,149 people) |
| Pancreatic exocrine insufficiency | 4.6% (2 studies, 478 people) |
| Microscopic colitis | 3% (17 studies, 5,068 people) |
The authors report that rates of all these conditions were significantly higher than in healthy controls, and concluded that a significant proportion of people presenting to secondary care with IBS have an organic condition that may account for their symptoms (Poon 2022).
Two cautions keep these numbers honest. First, they come from secondary care, meaning people already referred to a specialist, so they overestimate what a typical person with mild symptoms in primary care will have. Second, "malabsorption on a breath test" and "SIBO on a breath test" are not the same as "this is what is causing my symptoms." The SIBO gap alone, 49% with one test and 19% with the other, shows how much the answer depends on the test used. Breath-test results are clues for a clinician to weigh, not verdicts.
If you want one sentence to carry into an appointment, it is this: "My symptoms have been labeled IBS. Which of the common look-alikes have we checked, and which were not necessary for my pattern?"
Is IBS a diagnosis of exclusion?
Not any more, at least not by guideline. The 2021 ACG guideline suggests using a positive diagnostic strategy, compared with a strategy of exclusion, to improve time to starting appropriate therapy (Lacy 2021). The 2021 British Society of Gastroenterology guideline likewise reflects the reclassification of IBS as a disorder of gut-brain interaction (Vasant 2021).
The evidence behind that shift is a Danish randomized trial of 302 primary care patients aged 18 to 50 who met Rome III criteria and had no alarm signals. One group had an exclusion work-up (blood and stool tests for parasites, and sigmoidoscopy with biopsies); the other had a positive strategy with a blood count and C-reactive protein only. At one year the positive strategy was noninferior for quality of life, cost less, and produced similar symptom, satisfaction and health-care use outcomes. No cases of IBD, colorectal cancer or celiac disease were found in the trial (Begtrup 2013).
A review of how to exclude IBD in people with IBS-type symptoms makes the same point from the other side: a diagnosis based on symptom criteria, with alarm features excluded, is accurate and durable, yet many clinicians still treat IBS as exclusion because they fear missing IBD or another organic disease. Biomarker tests are shifting that comfort level (Nemakayala 2019).
What this means for you: a short, targeted set of tests is normal and good practice, and "we did a long list of tests and found nothing" is not the only route to an IBS diagnosis. It also means the tests should match your pattern. Someone with watery diarrhea has a different list from someone with constipation and straining. For the symptom criteria themselves, our Rome IV IBS criteria checker walks through them, though only a clinician can apply them to you.
How do you tell each IBS look-alike apart, and what test checks it?
This is the part most lists skip. For every condition below, the left column says what makes it hard to tell from IBS, the middle gives a clue that tends to point away from plain IBS, and the right names the test a clinician typically uses to check. None of these clues is proof on its own. Treat them as prompts for a conversation.
| Look-alike | A clue that may separate it | How it is checked |
|---|---|---|
| Celiac disease | Diarrhea, bloating, abdominal pain, weight loss; also non-gut signs such as anemia, abnormal liver tests or bone disease; many people have no symptoms at all (Rubio-Tapia 2013) | Celiac serology, with biopsy to confirm; both done while still eating gluten (Rubio-Tapia 2013) |
| IBD (Crohn's, ulcerative colitis) | Inflammation shows up in stool and blood markers; IBS does not reliably change them (Menees 2015) | Fecal calprotectin and CRP as screens; colonoscopy if raised or alarm features (Lacy 2021, Menees 2015) |
| Bile acid diarrhea | Watery diarrhea, found in about 28% of IBS-D in a pooled SeHCAT analysis (Slattery 2015) | SeHCAT retention testing was the method in those studies; access varies by country (Slattery 2015) |
| Microscopic colitis | Chronic watery diarrhea with a normal-looking colon; about one third of people with it report IBS-compatible symptoms (Kamp 2016) | Colonoscopy with biopsies; routine biopsy in typical IBS is of uncertain value unless risk factors or alarm symptoms are present (Kamp 2016) |
| SIBO | Bloating and diarrhea; breath test results swing between tests (Poon 2022) | Breath testing, interpreted by a clinician (Pimentel 2020) |
| Lactose or fructose intolerance | Symptoms that track specific foods; lactose malabsorption is common in IBS but malabsorption alone is not the same as intolerance (Varju 2019) | Breath testing for lactose or fructose (Poon 2022) |
| Exocrine pancreatic insufficiency | Dyspepsia was independently associated with it in IBS-D (Olmos 2022) | Fecal elastase stool testing (Olmos 2022) |
| Endometriosis | Cyclical pelvic pain or symptoms; roughly threefold odds of IBS alongside it (Chiaffarino 2021) | Gynecologic assessment; further imaging or surgery is a specialist decision |
| Ovarian cancer | Bloating with increased abdominal size and urinary symptoms; new, frequent or severe (Goff 2004) | Prompt medical evaluation; investigation for symptoms that are more severe or recent than expected (Goff 2004) |
| Thyroid disease | Diarrhea with hyperthyroidism, constipation with hypothyroidism; GI symptoms may be the only clue (Xu 2024) | Clinician-ordered thyroid function blood tests |
| Pelvic floor dysfunction | Straining, incomplete emptying, difficulty passing stool despite urge (Rao 2016) | Anorectal manometry and balloon expulsion test (Rao 2016) |
| Medication effect | Symptoms that began after a new medicine; drugs are a recognized cause of secondary constipation (Rao 2016) | Medication review with your prescriber (do not stop anything on your own) |
| Bowel cancer | Blood, weight loss, anemia, later-life onset; rare cause of constipation-type symptoms (Rao 2016) | Colonoscopy, chosen on alarm features and age |
The sections that follow explain each row in plain language.
Can celiac disease be mistaken for IBS?
Celiac disease can cause diarrhea, bloating and abdominal pain, exactly the IBS picture, but it also causes weight loss, anemia, abnormal liver tests, bone disease and skin problems, and many people have no symptoms at all (Rubio-Tapia 2013). In a meta-analysis of 14 studies, biopsy-proven celiac disease was found in 4.1% of adults meeting IBS criteria, and the odds were 4.34 times those in people without IBS (Ford 2009).
That is the reason the ACG suggests celiac serology for people with IBS and diarrhea symptoms (Lacy 2021). The detail people most often miss is timing: both serology and biopsy are intended to be done on a gluten-containing diet (Rubio-Tapia 2013). Cutting out gluten before testing can make a real celiac result look normal, so if you are considering a trial of gluten-free eating, test first and ask your doctor how long to keep eating gluten. Our full guide, celiac disease versus IBS, goes deeper on this.
Can inflammatory bowel disease be mistaken for IBS?
IBD is the look-alike people worry about most, and the one the guidelines screen for most deliberately. The ACG suggests checking fecal calprotectin in people with suspected IBS and diarrhea to rule out IBD (Lacy 2021). A meta-analysis found that at a CRP of 0.5 or less, or a calprotectin of 40 micrograms per gram or less, the probability of IBD was 1% or lower in people with IBS symptoms, while none of the biomarkers reliably separated IBS from healthy controls (Menees 2015).
A normal result is reassuring, not absolute. A review concluded that fecal calprotectin is the most sensitive preliminary test for telling IBD from IBS and that it helps identify who needs a colonoscopy, but no fecal or serum test can definitively identify IBD (Nemakayala 2019). Blood in the stool, weight loss, waking at night to pass stool and anemia are not explained by IBS and should prompt a doctor visit regardless of a recent normal test. For a symptom-by-symptom comparison, see IBS versus IBD.
Can bile acid diarrhea be mistaken for IBS?
Bile acid diarrhea happens when too many bile acids reach the colon, where they pull water in and speed things up. In a systematic review of six studies (908 people) using SeHCAT retention testing, 28.1% of people meeting IBS-D criteria had bile acid malabsorption, with a range of 16.9% to 35.3% and considerable variation between studies (Slattery 2015). The later 2022 pooled analysis, which included more studies and methods, put the figure at 41% (Poon 2022). The gap between 28% and 41% is a reminder that these estimates depend on how the studies were done.
The clue people report is urgent, watery diarrhea that feels unrelated to what they ate, sometimes with stools that wake them. That is a lived-experience pattern, not a diagnostic rule. SeHCAT retention testing is how it was measured in those studies, though availability varies. We cover this in more depth in bile acid malabsorption versus IBS. Whether to test, and what to do with a result, is a conversation for your gastroenterology team.
Can microscopic colitis be mistaken for IBS?
Microscopic colitis causes chronic watery diarrhea, and the colon looks normal at colonoscopy, so the diagnosis depends on biopsies. A meta-analysis found that about a third of people with microscopic colitis report symptoms compatible with IBS, but that IBS was no more common in them than in other people with diarrhea. People with IBS were also no more likely to have microscopic colitis than other people with diarrhea (Kamp 2016).
Those authors concluded that the value of routine colonoscopy and biopsy to exclude microscopic colitis in people with typical IBS symptoms remains uncertain unless other risk factors or alarm symptoms are present (Kamp 2016). In practice this is where a clear history helps. Persistent watery diarrhea, especially if it started more recently, comes with night-time bowel movements, or follows a new medicine, is the kind of detail worth telling your clinician, who decides whether biopsies are appropriate. Pooled prevalence among people meeting IBS criteria was about 3% (Poon 2022), so it is a relatively uncommon but important one.
Can SIBO be mistaken for IBS?
SIBO means excessive bacteria in the small bowel causing gastrointestinal symptoms. The ACG has a dedicated guideline on diagnostic criteria, testing and treatment (Pimentel 2020). In people meeting IBS criteria, pooled SIBO prevalence was 49% by lactulose breath test and 19% by glucose breath test (Poon 2022).
Take that spread seriously. When two common tests disagree by a factor of two or more, a single positive or negative result should be read with a specialist's help, and a positive test does not by itself explain why someone has symptoms. Our article on SIBO versus IBS symptoms compares the symptom pictures and the testing debate.
Can lactose or fructose intolerance be mistaken for IBS?
Lactose and fructose malabsorption are very common in people meeting IBS criteria on breath testing (54% and 43% respectively in the pooled data) (Poon 2022). But malabsorption is not the same as intolerance. A meta-analysis found that lactose intolerance, meaning symptoms after lactose, was more frequent in IBS than in healthy controls (odds ratio 2.5 for objectively assessed intolerance and 3.5 for self-reported), while lactose maldigestion itself was not significantly different (Varju 2019).
The takeaway is that a food-related pattern is real information, but it does not distinguish "it is IBS and lactose is a trigger" from "it is lactose intolerance mimicking IBS" without a plan. Many people have both. See lactose intolerance versus IBS for a practical comparison. If you are thinking about removing a food group, do it with your clinician or a dietitian, not on your own for months.
Can exocrine pancreatic insufficiency be mistaken for IBS?
Exocrine pancreatic insufficiency (EPI) means the pancreas is not delivering enough digestive enzymes. In 140 people meeting Rome IV criteria for IBS-D at tertiary clinics, a fecal elastase test found EPI in 5%, and dyspepsia was an independent factor associated with it (Olmos 2022). The pooled estimate in the 2022 review was 4.6% from two studies, a small evidence base (Poon 2022).
The practical clue is upper-gut symptoms (fullness, discomfort after eating) alongside loose stools. Do not treat that as a rule of thumb: it is a reason to mention those symptoms to your clinician, who can decide whether a stool elastase test is reasonable. Interpreting the result belongs to a professional.
Can endometriosis be mistaken for IBS?
Endometriosis is the mimic that comes up again and again when women compare notes. In r/ibs, a post titled "Turns out my IBS was endometriosis" drew hundreds of upvotes and a thread full of people describing years of bowel symptoms, painful periods and a long road through scans before anyone looked at the pelvis (r/ibs thread). That is lived experience, not evidence, but it matches what the research says.
A meta-analysis of 11 studies found that women with endometriosis had about 3.26 times the odds of IBS compared with women without it, and about twice the risk of developing IBS afterwards. The authors noted that the two conditions may coexist and be misdiagnosed for each other, which delays diagnosis, leads to mismanagement and causes unnecessary testing (Chiaffarino 2021).
If your bowel symptoms vary with your cycle, or you have painful periods, pain with sex or pain when you pass stool around your period, say so explicitly, with dates. Those details are exactly what a cycle-aware log captures. Endometriosis can only be assessed by a clinician, and neither this article nor a tracker can tell you that you have it.
Can ovarian cancer or other pelvic causes be mistaken for IBS?
Ovarian cancer is rare, but it is the mimic where missing it matters most, because early symptoms are vague: bloating, pelvic or abdominal pain and urinary urgency. In a case-control study of 1,709 primary care patients and 128 women with a pelvic mass, the combination of bloating, increased abdominal size and urinary symptoms was found in 43% of those with ovarian cancer but in only 8% of women attending primary care clinics. The authors concluded that symptoms more severe or frequent than expected and of recent onset warrant diagnostic investigation (Goff 2004).
The detail that separates this from typical IBS bloating is onset and persistence. Bloating that is new in adulthood, constant rather than coming and going, and joined by a visibly larger abdomen or urinary symptoms deserves a prompt visit. Do not wait for diet changes to settle it. This is not a reason for panic, just a reason to be specific with your doctor about when it started.
Can thyroid disease be mistaken for IBS?
Thyroid disorders can shift gut motility in both directions. A 2024 review notes that hyperthyroidism commonly shows malabsorption and diarrhea, hypothyroidism frequently shows constipation, and that gastrointestinal symptoms may sometimes be the only clue to underlying thyroid disease (Xu 2024). That makes thyroid disease a plausible alternative explanation for someone whose symptoms came on with fatigue, weight change, a racing heart or feeling unusually cold or hot.
If you have those other symptoms, mention them. A blood test is the ordinary way a clinician checks thyroid function; it is not something to guess at from a symptom list.
Can pelvic floor dysfunction be mistaken for IBS?
Not all constipation is slow transit. Dyssynergic defecation is a problem of coordinating the rectal and pelvic floor muscles that causes difficulty passing stool, and it is identified with anorectal manometry and a balloon expulsion test (Rao 2016). It can coexist with IBS-C or be labeled as IBS-C.
Clues people describe include repeated straining, a feeling that stool is stuck, needing to press on the perineum or the vagina, or passing hard stool only with great effort. The review notes that primary chronic constipation is a diagnosis made after secondary causes are excluded, and that dyssynergic defecation is best managed with biofeedback therapy, a specialist-supervised approach (Rao 2016). If you have been trying fiber and laxative strategies for a long time with little change, ask whether pelvic floor testing is appropriate.
Can medicines mimic IBS, and what should you do about them?
Medicines can mimic IBS. The constipation review lists drug treatment, along with neurological or metabolic conditions and, rarely, colon cancer, among the causes of secondary constipation (Rao 2016). Diarrhea can also be a medicine side effect, which is why a recent start date is a valuable clue.
The safe version of this advice is deliberately boring. Write down every prescription, over-the-counter product and supplement you take, with start dates, and bring the list to your doctor or pharmacist. Do not stop, start or change anything on your own because of something you read here. If you suspect a medicine is involved, ask your prescriber what the options are.
Can bowel cancer be mistaken for IBS, and why do alarm features matter?
Bowel cancer is rare in people with typical IBS symptoms and no alarm features. In the Danish trial of people aged 18 to 50 with no alarm signals, no colorectal cancer was found (Begtrup 2013). That is why guidelines do not send everyone to colonoscopy. A meta-analysis on microscopic colitis makes the same logic explicit: routine colonoscopy is of uncertain value in typical IBS unless other risk factors or alarm symptoms are present (Kamp 2016).
Which brings us to the red flags. These are not IBS features, and each warrants seeing a doctor promptly:
- Blood in your stool, or black stools.
- Unexplained weight loss.
- Fever.
- Anemia or persistent unexplained fatigue with pallor.
- Waking at night to open your bowels or with pain.
- Symptoms that start after age 50.
- A family history of bowel cancer, IBD or celiac disease.
- A new, persistent change in bowel habit that does not settle.
- Persistent new bloating with a visibly larger abdomen (particularly in women).
The gut red flags checker on this site helps you see which of these apply to you before an appointment; it is a prompt for a conversation, not a result. And if you are unsure whether you should be seen at all, our piece on when to see a gastroenterologist for IBS covers that decision.
What happens when doctors rule out other conditions?
A reasonable first-line approach, based on the ACG suggestions, is to apply symptom criteria, check for alarm features, and run a few targeted tests chosen by your pattern (Lacy 2021). For IBS with diarrhea, that is celiac serology and fecal calprotectin. A blood count and CRP are a common addition, as in the Danish trial (Begtrup 2013).
If those are clear and there are no alarm features, many clinicians will make a positive diagnosis of IBS and begin management. If something does not fit, such as a poor response to usual measures, a pattern that changes, or new alarm features, the next layer of testing is chosen from the look-alikes above. Colonoscopy is usually driven by alarm features or age-based screening, not by IBS alone.
Notice what you cannot do from the outside: pick the tests. Notice what you can do: supply the history that guides the choice.
Can an IBS diagnosis be wrong, and what do the numbers say?
An IBS diagnosis can be wrong in two different ways, and they are worth separating.
The first is the wrong condition: someone who meets the criteria actually has bile acid diarrhea, celiac disease or another treatable cause. The pooled data above show this is far from rare in specialist settings (Poon 2022). Because those studies include people referred onward, they probably overstate what happens in a straightforward primary care case.
The second is the overlap: you have IBS and another condition. This is common. Endometriosis and IBS, lactose malabsorption and IBS, and microscopic colitis and IBS-type symptoms all coexist often enough that "I have IBS" and "I also have X" can both be true (Chiaffarino 2021, Kamp 2016).
What we cannot give you is a single misdiagnosis rate for IBS. Studies measure different groups with different methods, and anyone quoting one number is oversimplifying. What the evidence does support is the practical rule: a symptom-based diagnosis is reasonable without alarm features, and it should be revisited if new features appear or the expected response does not.
What do people on Reddit say when it was not just IBS?
Reading r/ibs, a few themes show up repeatedly in threads titled along the lines of "it wasn't just IBS". People describe a long gap between first symptoms and an answer, a sense that the label closed the conversation, and relief when a specific cause was finally found. One widely upvoted thread names a parasite found after years of an IBS label, another endometriosis, another an environmental trigger at home. These are individual stories, and some of the causes in them are unusual, so they are not a guide to what is likely. What they do show is how much a clear timeline matters: those who got further tended to bring dates, patterns and specific questions.
We use these threads only as a view into the questions people have. The medical statements in this article come from the cited papers and guidelines.
How does a symptom log help a clinician tell these apart?
Most of the clues in the table above are timing clues. A clinician cannot see when your pain peaks, which days you woke at night, or whether it follows your cycle, a meal or a medicine. You can. A log with dates turns "it comes and goes" into a pattern that someone can reason about.
Here is what to record, and which look-alike each detail might help a clinician think about:
| What to log | Why it helps |
|---|---|
| Start date of the current pattern, and anything that changed in the prior weeks (new medicine, infection, travel, big life event) | Medicine effects and post-infection changes have a start point |
| Stool form (Bristol type) and frequency, by day | Separates diarrhea-type from constipation-type patterns and shows change over time |
| Blood or mucus in stool, and urgency | Alarm-feature details that change the work-up |
| Night-time wake-ups to open your bowels | Not typical of IBS; worth raising promptly |
| Cycle day (if relevant) alongside pain and bowel symptoms | Cyclical patterns may point toward endometriosis or hormonal effects |
| Meals, especially dairy, wheat and high-fructose foods, with timing | Food-linked patterns point toward intolerance conversations, with the caveat that delays can be hours to days |
| Straining, incomplete emptying, needing to press to pass stool | Pelvic floor clues |
| Fatigue, weight change, palpitations, temperature intolerance | Thyroid and other non-gut clues |
| Every medicine and supplement, with start date | Allows a medication review |
Two things make this more useful than a mental summary. Recording at the time avoids the recall bias that blurs weeks into one impression, and a few weeks of entries show variation that a single appointment cannot. Our guides on what to track in a symptom diary and preparing for a GI appointment go through the practical details.
Clairop logs meals, symptoms and stool in seconds, then looks for the foods your gut reacts to, including reactions that land days later.
A paper notebook works fine. If you prefer your phone, the how it works page and method page describe what Clairop logs and how its analysis handles timing, and it is not a medical device or a diagnostic tool.
Myths about what can mimic IBS
"If the tests are normal, it must be IBS and nothing else." Normal screening tests make some serious conditions less likely. They do not rule out every look-alike. Calprotectin and CRP are strong for IBD, for instance, but say nothing about bile acid diarrhea or pelvic floor problems (Menees 2015).
"IBS needs a colonoscopy before it can be diagnosed." For most people without alarm features, guidelines support a positive diagnosis without one (Lacy 2021). Alarm features and age change that.
"A positive breath test means I have SIBO and that explains everything." Breath test results vary a lot between methods (49% versus 19% in one pooled analysis), and a positive test needs clinical interpretation (Poon 2022).
"Cutting out gluten is a harmless way to test for celiac disease." It can make later testing unreliable, because serology and biopsy are meant to be done on a gluten-containing diet (Rubio-Tapia 2013).
"Women's bloating is just IBS." It often is, but pelvic conditions such as endometriosis are common enough alongside IBS that new or cyclical symptoms deserve a gynecologic conversation (Chiaffarino 2021).
"Having a mimic means my IBS diagnosis was wrong." Often the two coexist. Treating one does not always clear the other.
A worked example
Consider a fictional person, not a real case. A 34-year-old has had loose stools for eight months, labeled IBS-D by a family doctor. She keeps a log for four weeks. It shows watery stools most mornings, urgency that makes her leave the house late, two nights in which she woke to open her bowels, and a loose pattern that is worse in the week before her period, when she also has pelvic pain and painful sex.
None of that diagnoses anything. But it gives her doctor several leads at once. Night-time waking is not typical of IBS and is the sort of detail clinicians take seriously. The cyclical pelvic pain raises the endometriosis conversation. Persistent watery diarrhea with night episodes raises the questions about celiac serology, calprotectin and possibly more. Without the log, she might say "it's just bad all the time", and the visit would end with the same label.
When to see a doctor promptly
See a doctor promptly, and do not wait for diet or tracking to answer it, if you have blood in your stool, black stools, unexplained weight loss, fever, anemia, symptoms that wake you at night, symptoms starting after age 50, new persistent bloating with a swelling abdomen, or a family history of bowel cancer, IBD or celiac disease. Go urgently if you have severe pain, repeated vomiting, a rigid swollen belly or you cannot pass stool or gas.
If none of those apply but you have had symptoms for months, nothing has helped, or you are unsure what has been checked, it is reasonable to ask your clinician which look-alikes have been considered. The ACG recommends a limited trial of a low FODMAP diet in IBS (Lacy 2021), but it is a short elimination and reintroduction process best done with a dietitian, and it is not a substitute for ruling out other conditions.
What questions should you bring to your appointment?
- Which tests have been done, and which of the common look-alikes do they cover?
- Do my symptoms include any alarm features that change the plan?
- Have celiac serology and fecal calprotectin been checked, and was I eating gluten when they were done?
- Could a medicine I take be contributing?
- Given my pattern, are any of bile acid testing, breath testing or pelvic floor testing reasonable?
- If I am a woman with cyclical or pelvic symptoms, should a gynecologist be involved?
- What would make you reconsider the IBS diagnosis?
- When should I come back if nothing changes?
The bottom line
IBS is a real, common, positively diagnosed condition, and for most people without alarm features it is the right label. But it is a symptom pattern, and several treatable conditions share it. The best evidence we have shows that in specialist settings look-alikes are frequent, that a short targeted set of tests is endorsed by guidelines, and that red flags always change the plan. If something about your story does not fit, you are not being difficult by asking what else was considered. Bring dates, patterns and specific questions, and see a doctor promptly if any red flag applies.
For related reading, see our companion piece on what can be mistaken for ulcerative colitis, the comparison of IBS and IBD, and the guide to seeing a gastroenterologist for IBS.




